News

Here’s how everyday investors are getting started. If you want to make $100 per month — $1,200 annually — from Pfizer dividends, your investment value needs to be approximately $15,666 ...
Pfizer has axed its oral GLP-1 asset danuglipron after one patient had potential drug-induced liver injury in a phase 1 trial. The setback blows a hole in the Big Pharma’s plans to challenge for ...
Matthew Herper covers medical innovation — both its promise and its perils. Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron ...
Pfizer shares fell 1.32% after reports U.S. prosecutors are investigating claims from GSK about the timing of Pfizer’s COVID-19 vaccine. Pfizer denies allegations of delaying vaccine results for ...
British drugmaker GSK told Manhattan prosecutors that a former employee told colleagues Pfizer held back positive results until after the 2020 election. But the former employee, who worked at both ...
Given its better valuation, we believe that Pfizer stock (NYSE: PFE) is currently a better pick than its industry peer – AbbVie stock . PFE stock trades at a much lower multiple of 11x forward ...
He also noted that Pfizer boasts a commercial presence in more than 100 countries and a customer-facing commercial team that is triple the size of Seagen’s. He did not elaborate onspecific sales ...
by 100 employees. The staffers worked on production of Pfizer’s COVID-19 antiviral Paxlovid, the company confirmed in an emailed statement. “Onsite operations were expanded in 2021 to meet ...
Pfizer also said it would also take measures to save at least $3.5 billion through the end of 2024. (Photo by PASCAL POCHARD-CASABIANCA/AFP via Getty Images) (pascal pochard-casabianca/Agence ...
July 18 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab and venture firm Flagship Pioneering on Tuesday said they would invest $100 million together to develop up to 10 new potential ...
Pfizer's 2022 total revenue of $100.3 billion was a record for the pharmaceutical company, and it is what allowed it to go on an acquisition spree, including its latest deal with Seagen.
The packaging for Pfizer's Nurtec ODT, a prescription medication used to treat and prevent migraines, is not child resistant – prompting a recall notice from the CPSC. Consumers don't need to ...